Cargando…

A UK Survey Examining the Experience of Adults With Mastocytosis Receiving COVID-19 Vaccination

Detalles Bibliográficos
Autores principales:	Sriskandarajah, Priya, Hobart, Jess, Radia, Deepti H., Whyte, Andrew F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517291/ https://www.ncbi.nlm.nih.gov/pubmed/34667940 http://dx.doi.org/10.1097/HS9.0000000000000650

Ejemplares similares

Large Scale Internet-based Survey of Patients With a Myeloproliferative Neoplasm: Opinions and Experiences Regarding SARS-CoV-2 (COVID-19) Vaccination Strategies in 2021
por: Saunders, Jamie, et al.
Publicado: (2021)

P1014: OVERALL SURVIVAL IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS RECEIVING AVAPRITINIB VERSUS MIDOSTAURIN OR CLADRIBINE
por: Reiter, A., et al.
Publicado: (2022)

Anesthetic experience in a pediatric patient with mastocytosis
por: Jo, Youn Yi, et al.
Publicado: (2011)

Efficacy of avapritinib versus best available therapy in the treatment of advanced systemic mastocytosis
por: Reiter, Andreas, et al.
Publicado: (2022)

SARS-CoV-2 vaccines are well tolerated in patients with mastocytosis
por: Tuncay, Gülseren, et al.
Publicado: (2022)

Anaesthesia in a patient with mastocytosis
por: Maheshwari, Shivi, et al.
Publicado: (2022)

Dermoscopic findings of pseudoxanthomatous mastocytosis localized on vulva
por: Li, Qiaofei, et al.
Publicado: (2018)

COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)
por: Bonadonna, Patrizia, et al.
Publicado: (2021)

Bullous congenital diffuse cutaneous mastocytosis()()
por: Cardoso, Julia Marcon, et al.
Publicado: (2020)

Mastocytosis in the skin in children and adults
por: Lange, Magdalena
Publicado: (2015)

Transcriptomic profiling does not refine mastocytosis diagnosis
por: Buschhorn, Lars, et al.
Publicado: (2023)

Challenges in applying diagnostic criteria for systemic mastocytosis
por: Boggs, Nathan A., et al.
Publicado: (2023)

Systemic mastocytosis with an associated hematological neoplasms: One or two entities?
por: Njue, Linet, et al.
Publicado: (2020)

Drugs and Vaccines Hypersensitivity in Children with Mastocytosis
por: Mori, Francesca, et al.
Publicado: (2022)

Delayed Diagnosis of Adult Indolent Systemic Mastocytosis
por: Mikkelsen, Carsten Sauer, et al.
Publicado: (2014)

Congenital cutaneous mastocytosis mistaken for non‐accidental injury
por: Porter, Emma, et al.
Publicado: (2023)

Mast cells derived from systemic mastocytosis exhibit an increased responsiveness to hyperosmolarity
por: Lyberg, Katarina, et al.
Publicado: (2022)

Engraftment in NSG(SCF) mice correlates with the WHO category and prognosis in systemic mastocytosis
por: Willmann, Michael, et al.
Publicado: (2023)

A French National Survey on Clotting Disorders in Mastocytosis
por: Carvalhosa, Ana B., et al.
Publicado: (2015)

Melanoma and Mastocytosis
por: Vojvodic, Aleksandra, et al.
Publicado: (2019)

Efficacy and safety of avapritinib in previously treated patients with advanced systemic mastocytosis
por: Reiter, Andreas, et al.
Publicado: (2022)

Clinical Outcomes of Adults with Systemic Mastocytosis: A 15-Year Multidisciplinary Experience
por: Ungerstedt, Johanna, et al.
Publicado: (2022)

Mastocytosis in children and adults: clinical disease heterogeneity
por: Lange, Magdalena, et al.
Publicado: (2012)

Massive splenomegaly: flow cytometry as a diagnostic tool for systemic mastocytosis
por: Rastogi, Loveena, et al.
Publicado: (2018)

Liver fibrosis and its response to avapritinib in 2 patients with systemic mastocytosis
por: Cavazos, Karla, et al.
Publicado: (2022)

How persons with systemic mastocytosis describe the time between symptom onset and receiving diagnosis
por: Hamberg Levedahl, Kerstin, et al.
Publicado: (2022)

The MRCP(UK) Exam: An Examiner's View
por: Cahill, Mary
Publicado: (1994)

Is the MRCP(UK) Examination a Dinosaur?
por: Jolobe, O M P
Publicado: (1995)

P1013: OVERALL SURVIVAL IN PATIENTS WITH SYSTEMIC MASTOCYTOSIS WITH ASSOCIATED HEMATOLOGIC NEOPLASM TREATED WITH AVAPRITINIB VERSUS BEST AVAILABLE THERAPY
por: Reiter, A., et al.
Publicado: (2022)

Twelve-Hour Ultrarush Immunotherapy in a Patient With Mastocytosis and Hymenoptera Sting Anaphylaxis
por: Jäger, Doris, et al.
Publicado: (2009)

A case of lymphocytic variant hypereosinophilic syndrome with sub-diagnostic systemic mastocytosis
por: Jain, Preetesh, et al.
Publicado: (2017)

Pediatric Mastocytosis: An Update
por: Giona, Fiorina
Publicado: (2021)

Cutaneous mastocytosis in childhood
por: Nemat, Katja, et al.
Publicado: (2022)

Avapritinib for Cutaneous Mastocytosis
por: LEE, Hannah, et al.
Publicado: (2021)

Mastocytosis in the Skin: Disease Heterogeneity among Children and Adults
por: FOKOLOROS, Christos, et al.
Publicado: (2023)

Autistic adults’ views and experiences of requesting and receiving workplace adjustments in the UK
por: Davies, Jade, et al.
Publicado: (2022)

Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial
por: DeAngelo, Daniel J., et al.
Publicado: (2021)

Transient hypogammaglobulinaemia of infants in children with mastocytosis – strengthened indications for vaccinations
por: Renke, Joanna, et al.
Publicado: (2016)

Systemic Mastocytosis with Associated Chronic Lymphocytic Leukemia: A Matter of Diseases or Prognostic Factors?
por: Zagaria, Antonella, et al.
Publicado: (2017)

P1015: DURATION OF TREATMENT AND REDUCTION IN SERUM TRYPTASE LEVELS IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS TREATED WITH AVAPRITINIB VERSUS BEST AVAILABLE THERAPY
por: Reiter, A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2ibo9k0apj83k3ltb3phbaka7p